CI:NYE-Cigna Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 363.34

Change

+5.61 (+1.57)%

Market Cap

USD 35.85B

Volume

1.47M

Analyst Target

USD 242.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+1.49 (+0.30%)

USD 404.91B
ELV Elevance Health Inc

-2.42 (-0.45%)

USD 123.51B
CVS CVS Health Corp

-0.15 (-0.22%)

USD 87.92B
CNC Centene Corp

-1.68 (-2.22%)

USD 37.83B
HUM Humana Inc

-5.51 (-1.77%)

USD 37.75B
MOH Molina Healthcare Inc

-10.07 (-2.86%)

USD 22.06B
OSCR Oscar Health Inc

-0.33 (-1.84%)

USD 3.68B
NEUE NeueHealth Inc

-0.22 (-3.54%)

N/A

ETFs Containing CI

PINK Simplify Exchange Traded .. 6.48 % 0.00 %

-0.04 (1.20%)

USD 0.12B
FHI-B:CA CI Health Care Giants Cov.. 5.11 % 0.00 %

N/A

CAD 0.05B
ZWHC:CA BMO Covered Call Health C.. 4.78 % 0.00 %

N/A

CAD 0.01B
AILV 4.45 % 0.00 %

N/A

N/A
STNC Stance Equity ESG Large C.. 3.75 % 0.00 %

-0.03 (1.20%)

USD 0.11B
WHCS:SW iShares MSCI World Health.. 3.25 % 0.00 %

N/A

USD 1.07B
FSST Fidelity Sustainability U.. 2.42 % 0.00 %

+0.32 (+1.20%)

USD 0.01B
TDOC:CA TD Global Healthcare Lead.. 2.28 % 0.00 %

+0.01 (+1.20%)

CAD 0.07B
FHH:CA First Trust AlphaDEX US H.. 2.28 % 0.77 %

N/A

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.28 % 0.00 %

N/A

CAD 0.01B
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.27 % 0.00 %

-0.02 (1.20%)

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.27 % 0.00 %

-0.02 (1.20%)

USD 0.35B
UPVLH:SW 2.27 % 0.00 %

N/A

N/A
NSCR Nuveen Sustainable Core E.. 2.09 % 0.00 %

+0.30 (+1.20%)

USD 5.49M
RSPH Invesco S&P 500® Equal.. 1.65 % 0.00 %

+0.12 (+1.20%)

USD 1.02B
CSY9:XETRA Credit Suisse Index Fund .. 1.46 % 0.00 %

+1.36 (+1.20%)

USD 0.29B
IQSA:LSE Invesco Quantitative Stra.. 1.45 % 0.00 %

+0.93 (+1.20%)

USD 0.24B
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.66 % 0.00 %

+0.13 (+1.20%)

USD 1.17B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.42 % 0.00 %

+0.39 (+1.20%)

USD 0.56B
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.01 (+1.20%)

USD 5.46M
FUM:CA 0.00 % 0.80 %

N/A

N/A
FXH First Trust Health Care A.. 0.00 % 0.63 %

+0.18 (+1.20%)

USD 1.33B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.19 (1.20%)

USD 0.82B
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.08B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.22 (+1.20%)

USD 0.05B
RYH 0.00 % 0.40 %

N/A

N/A
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

-0.10 (1.20%)

USD 0.11B
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.16 (+1.20%)

CAD 0.35B
WBIL WBI BullBear Quality 3000.. 0.00 % 1.07 %

-0.01 (1.20%)

USD 0.04B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+0.19 (+1.20%)

USD 0.08B
XXM:CA 0.00 % 0.68 %

N/A

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+24.50 (+1.20%)

USD 0.35B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+11.25 (+1.20%)

USD 8.21M
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

+1.46 (+1.20%)

USD 4.20B
BUYB:PA Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.43 (+1.20%)

USD 0.05B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+2.10 (+1.20%)

USD 7.32M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.30 (+1.20%)

USD 0.35B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

+8.12 (+1.20%)

USD 0.27B
BBCK:F Invesco Markets III plc -.. 0.00 % 0.00 %

+0.58 (+1.20%)

USD 0.05B
UBUS:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.22 (+1.20%)

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.08 (+1.20%)

USD 0.02B
BBCK:XETRA Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.38 (+1.20%)

USD 0.05B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+7.97 (+1.20%)

USD 0.40B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.36 (+1.20%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.20 (+1.20%)

USD 0.05B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

+0.05 (+1.20%)

USD 1.13B
NTZG Nuveen Global Net Zero Tr.. 0.00 % 0.00 %

+0.28 (+1.20%)

USD 6.17M
AGED:SW iShares Ageing Population.. 0.00 % 0.00 %

+0.07 (+1.20%)

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

+0.10 (+1.20%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.34% 86% B+ 93% A
Dividend Return 0.47% 75% C 29% F
Total Return 21.80% 86% B+ 93% A
Trailing 12 Months  
Capital Gain 43.03% 71% C- 88% B+
Dividend Return 2.00% 75% C 29% F
Total Return 45.03% 71% C- 88% B+
Trailing 5 Years  
Capital Gain 125.93% 80% B- 89% A-
Dividend Return 9.23% 33% F 34% F
Total Return 135.16% 80% B- 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.45% 71% C- 80% B-
Dividend Return 15.68% 71% C- 80% B-
Total Return 1.23% 50% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 17.77% 86% B+ 62% D
Risk Adjusted Return 88.24% 71% C- 97% N/A
Market Capitalization 35.85B 57% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 67% 44%
Price/Book Ratio 2.13 71% 39%
Price / Cash Flow Ratio 8.24 57% 44%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 11.79% 57% 64%
Return on Invested Capital 16.91% 75% 80%
Return on Assets 3.75% 57% 62%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.